Search Results Search Sort by RelevanceMost Recent Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437. Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.” Case and Commentary Apr 2005 Board Certification as Prerequisite for Hospital Staff Privileges Joseph Lowy, MD Virtual Mentor. 2005;7(4):284-287. doi: 10.1001/virtualmentor.2005.7.4.ccas4-0504. Case and Commentary Jun 2005 Familial Genetic Risk David John Doukas, MD Virtual Mentor. 2005;7(6):417-421. doi: 10.1001/virtualmentor.2005.7.6.ccas4-0506. Health Law Jun 2005 A Physician's Role in Informing Family Members of Genetic Risk Faith Lagay, PhD Virtual Mentor. 2005;7(6):435-437. doi: 10.1001/virtualmentor.2005.7.6.hlaw1-0506. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Medicine and Society Oct 2003 Access to Mental Health Care: A Civil Rights Issue Ralph Ibson, JD Virtual Mentor. 2003;5(10):460-462. doi: 10.1001/virtualmentor.2003.5.10.msoc1-0310. Medical Education Oct 2003 Stigma, Society, and Specialty Choice: What's Going On? Sam Huber Virtual Mentor. 2003;5(10):436-439. doi: 10.1001/virtualmentor.2003.5.10.medu1-0310. Personal Narrative Oct 2003 Understanding Psychotropic Medications as Literary Symbols Jonathan M. Metzl, MD, PhD Virtual Mentor. 2003;5(10):470-472. doi: 10.1001/virtualmentor.2003.5.10.mhum1-0310. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437.
Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.”
Case and Commentary Apr 2005 Board Certification as Prerequisite for Hospital Staff Privileges Joseph Lowy, MD Virtual Mentor. 2005;7(4):284-287. doi: 10.1001/virtualmentor.2005.7.4.ccas4-0504.
Case and Commentary Jun 2005 Familial Genetic Risk David John Doukas, MD Virtual Mentor. 2005;7(6):417-421. doi: 10.1001/virtualmentor.2005.7.6.ccas4-0506.
Health Law Jun 2005 A Physician's Role in Informing Family Members of Genetic Risk Faith Lagay, PhD Virtual Mentor. 2005;7(6):435-437. doi: 10.1001/virtualmentor.2005.7.6.hlaw1-0506.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.
Medicine and Society Oct 2003 Access to Mental Health Care: A Civil Rights Issue Ralph Ibson, JD Virtual Mentor. 2003;5(10):460-462. doi: 10.1001/virtualmentor.2003.5.10.msoc1-0310.
Medical Education Oct 2003 Stigma, Society, and Specialty Choice: What's Going On? Sam Huber Virtual Mentor. 2003;5(10):436-439. doi: 10.1001/virtualmentor.2003.5.10.medu1-0310.
Personal Narrative Oct 2003 Understanding Psychotropic Medications as Literary Symbols Jonathan M. Metzl, MD, PhD Virtual Mentor. 2003;5(10):470-472. doi: 10.1001/virtualmentor.2003.5.10.mhum1-0310.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.